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Objective: to evaluate the efﬁcacy of hyaluronic acid in the post-operative of knee
arthroscopy.
Methods:  we have evaluated 49 patients undergoing arthroscopic procedure with the use of
intra-articular hyaluronic acid (Group 1) and 49 patients undergoing arthroscopic procedure
without  the use of hyaluronic acid (Group 2). Patients were evaluated based on the Visual
Analogue  Scale, household analgesia, assessment of the Range of Motion with a goniometer,
and  the Lysholm questionnaire.
Results:  there were no substantial adverse effects on either group.
Conclusion: the use of hyaluronic acid in the post-operative of knee arthroscopy is justiﬁed
due/because  it leads to a decrease in pain in the early stage, enabling faster recovery of the
patient.
©  2014 Sociedade Brasileira de Ortopedia e Traumatologia. Published by Elsevier Editora
Ltda.  
Avaliac¸ão  dos  resultados  do  uso  do  hialuronato  de  sódio  intra-articular
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Objetivo: avaliar a eﬁcácia do uso do ácido hialurônico no pós-operatório de artroscopia de
joelho.
Métodos:  foram avaliados 49 pacientes submetidos ao procedimento artroscópico associ-
Este é um artigo Open Access sob a licença de CC BY-NC-ND hialurônico intra-articular (Grupo I) e 49 pacientes submetidos aocido hialurônico ado  ao uso do ácido
iscossuplementac¸ão procedimento  artroscópico sem uso do ácido hialurônico (Grupo II). Os pacientes foram
avaliados  com base na Escala Visual Analógica de dor (EVA), analgesia domiciliar, amplitude
do  movimento do joelho com goniômetro e no questionário Lysholm.
Resultados:  não ocorreram efeitos adversos signiﬁcativos em nenhum dos dois grupos.
 Please cite this article as: de Paula Pereira Junior A, Fasolin RP, Sossa FAC, de Almeida Lira Neto O, Navarro MS, Milani A. Avaliac¸ão  dos
esultados do uso do hialuronato de sódio intra-articular no pós-operatório da artroscopia do joelho. Rev Bras Ortop. 2014;49:37–43.
 Study conducted at the Hospital Ifor, São Bernardo do Campo, SP, Brazil.
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Conclusão: o uso do ácido hialurônico no pós-operatório de artroscopia de joelho é justiﬁcado
por levar a uma diminuic¸ão  da dor na fase inicial e possibilitar uma recuperac¸ão  mais rápida
do paciente.
©  2014 Sociedade Brasileira de Ortopedia e Traumatologia. Publicado por ElsevierIntroduction
The use of intra-articular medication in the immediate post-
operative  period in the area of arthroscopic knee surgeries is
controversial, with prospects for new behaviors and routines,
and  with authors for and against the use of hyaluronic acid
post-operatively.1,2
A knee arthroscopy is a medical procedure more  usual
in  the United States of America (USA), and is effective for
symptom  relief in patients with intra-articular loose bodies,
chondral  injury and meniscal pathology.2
The performance of human joints is strictly related to the
viscoelastic properties of synovial ﬂuid, which determines the
strength  transmission, lubrication and protection of articular
cartilage.  This viscoelasticity depends on the concentration of
hyaluronic  acid in the sinovial ﬂuid.3
Other actions of hyaluronic acid would be an anti-
inﬂammatory effect (decreased gene expression of cytokines,
prostaglandin production, and intra-articular concentration of
metalloproteinases) and analgesic (inhibition of nociceptors),
stabilization of cartilaginous matrix, chondrocyte prolifera-
tion,  increased production of type II collagen and its decreased
degradation.4–6
Some authors believe that exogenous hyaluronic acid also
stimulates  the production of endogenous hyaluronic acid,
which  would explain its long-term effect.7 With respect to the
analgesic  effect of intra-articular hyaluronic acid, it is believed
that,  initially, it would be smaller than the intra-articular cor-
ticosteroid  injection, but with persistence for longer periods.8
Another source of debate is the discussion regarding the
number  of doses of hyaluronic acid to be effective, but there
was  no difference in the comparison between three and six
doses  at weekly intervals.9
Some authors claim that, during an arthroscopic knee
surgery, a decrease in intra-articular hyaluronic acid concen-
tration  may  occur and, as immediate therapy, recommend
intra-articular applications of sodium hyaluronate 20 mg
after  surgery, and subsequently four injections at weekly
intervals.10
The aim of this study was  to compare the results of the use
of  intra-articular sodium hyaluronate in a group of patients
undergoing arthroscopic surgery due to meniscal lesions ver-
sus results observed in a group of patients not treated by this
complementary therapy.
Materials  and  methodsNinety-eight patients with meniscal lesions were studied.
These  patients were  treated from March to November 2005 by
arthroscopic surgery with partial meniscectomy of the medial
meniscus,  always by the same surgical team.Editora  Ltda.  
Their ages ranged from 18 to 65 years (mean: 34 years).
Sixty-ﬁve (63%) were  men  and 33 (37%), women.
The participants were  randomly divided into two groups
of  49. The ﬁrst group was  treated with intra-articular sodium
hyaluronate 20 mg (Polireumim, TRB Pharma) in the imme-
diate  post-operative period and, subsequently, with a weekly
application  for four consecutive weeks. In the second group,
this  treatment was  not done. The surgeon was unaware of the
group  to which each patient belonged, having been informed
only  after skin suture, at the time of completion (or not) of the
inﬁltration  (Table 1).
All  patients were rehabilitated according to the same pro-
tocol,  with evaluations after three, eight, 15, 30 and 60 days,
and  were instructed to return to sport practice after 60 days of
surgery.
All  patients underwent the same surgical technique, with
the  use of only two infrapatellar portals (medial and lateral)
and,  on average, with joint infusion (6 L of saline 0.9%), using
an  infusion pump at a mean pressure of 50 mmHg. All ran-
domized  patients showed no signiﬁcant changes in cartilage
and,  in this study, only cases of Outerbridge grade I and II
chondropathy (Table 1) were  included.
All patients were anesthetized by subarachnoid block with
bupivacaine 0.5% associated with glucose 12.5 to 15 mg, with-
out  opioids. A pneumatic tourniquet was  also used, with an
average  time of 35 min.
After hospital discharge (mean: 12 h after the intervention),
both groups were treated with cephalexin 500 mg  PO 6/6 h for
seven  days and, in case of pain, dipyrone 50 drops to the limit
of  6/6 h. The use of analgesics was controlled in a form, in
which  the patient had to check the date and time of use until
the  eighth day.
In  Group 1, after skin suture the inﬁltrations were  made in
the  lateral suprapatellar area, (once a week for four consec-
utive  weeks). Besides the control on the form with the date
and  time of use of analgesics, patients underwent VAS. In all
reviews,  the range of motion of the knee was also measured
with  a goniometer; the Lysholm questionnaire was  applied
in  the preoperatory on the day of surgery and on the 15th,
30th  and 60th days post-operatively. All evaluations were  per-
formed  by the same examiner who did not know at which
group  the patient belonged.
To avoid bias in the results because of the pain of inﬁl-
tration, the assessments in the 8th, 15th and 30th days were
always  made before this procedure.
In the statistical analysis, analysis of variance with two fac-
tors  and repeated measures on the time factor were  made,
assuming a ﬁrst-order autoregressive correlation matrix
between time points.11 After the analysis, Tukey multiple com-
Este é um artigo Open Access sob a licença de CC BY-NC-NDparisons  were made12 to see between which groups or time
points  occurred differences in scales.
The tests were performed with a signiﬁcance level of 5%.
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Table 1 – Characterization of sample.
Variables n = 98 Group 1 = 49 Group 2 = 49
Age (years) – mean (SD) 34 (12.1) 36 (11.3) 33 (12.1)
Minimum–maximum 18–65 20–65 18–61
Gender – n (%)
Female 33 (37) 15 (30.6) 18 (36.7)
Male 65 (63) 34 (69.4) 31 (63.3)
Operated site – n (%)
Right  58 (59.2) 26  (53) 32 (65.3)
Left 40 (40.8) 23  (47) 17 (34.7)
Chondral lesiona – n (%)
Without lesion 43 (43.9) 22 (44.9) 21 (42.9)
Grade I 31 (31.6) 14 (28.6) 17 (34.7)
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onsidering the assessments by VAS, the results suggest more
apid  reduction of pain in Group 1 versus Group 2. The analysis
howed  that the mean behavior of VAS was  statistically differ-
nt  between groups over the evaluation time points (p < 0.001)
Fig.  1).
In  comparing the different evaluation time points, the data
n  Table 2 show that both groups had a mean reduction in VAS
ith  statistical signiﬁcance at all evaluation time points, when
ompared  to the previous time point (p < 0.001), but in the
ighth  and 15th days, Group 1 showed, on average, statistically
ower  VAS versus Group 2 (p < 0.001 and p < 0.001) and in other
ime  points, there was  no statistically signiﬁcant difference in
AS between groups (p > 0.05) (Table 2).
With  respect to the need for use of home analgesia, there
as  no statistical difference between the groups until the
ighth  day.
With  regard to assessments made with the goniometer, it
as  observed that after 15 days the Group 1 had greater range
f  motion versus Group 2. After 30 days, this difference could
till  be observed, to a lesser extent, but without statistical sig-
iﬁcance.  In the assessment made on the 60th day, the results
ere  similar in both groups.
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ig. 1 – Graphical representation of the mean proﬁles and
espective  standard errors of VAS, according to groups.13 (26.5) 11 (22.4)
In the evaluation with the Lysholm questionnaire (excel-
lent:  patients between 95 and 100 points, good: 94–84; regular:
83–65,  and poor score: <64), we noted in the preoperative that
the  Groups 1 and 2 had an average of 46 and 48 points, respec-
tively,  classiﬁed then as poor (Table 3).
Table 3 shows that in both Groups (1 and 2), the mean
Lysholm score decreased statistically from the preoperatory to
15 days post-operatively (p = 0.003 and p < 0.001, respectively),
with  “poor” rating in both groups. However, in the evaluation
of  the questions, we  found that the largest difference between
groups  was  observed in the items “pain” and “swelling”, in
which  the Group 1 had better results versus Group 2. In other
questions,  the results were similar between groups.
In  the 30th day the results showed the greatest statistical
difference between groups. Group 1 averaged 90 points, clas-
siﬁed  as good, and Group 2 averaged 77 points, classiﬁed as
regular.  We  perceived a greater difference in the questions
about  claudication, instability, swelling and squatting, and
noticed  that, just as that in the 15th day, the swelling was  also
an  important factor.
At  the last evaluation period, 60 days after the surgery, the
two  groups differed statistically, with 94 points in Group 1 and
90  points in Group 2, both classiﬁed as good. In this evaluation,
we  realized that the two groups differed primarily in the item
“climbing  stairs”, but without statistical difference between
values.
In  the allocation of the results of the Lysholm et al. ques-
tionnaire on a graph, earlier improvement of function in Group
1  versus Group 2 was  noted in all assessments (p < 0.001) (Fig. 2).
In  this study, some complications occurred: eight patients
in  Group 1 reported a need for analgesia after inﬁltration. In six
of these cases, two patients required only one dose of dipyrone
50  drops, and in two of them, two days of dipyrone 50 drops
8/8  h were  required.
None of the patients had post-operative infections, joint
stiffness,  or scar changes.Discussion
Hyaluronic acid is a natural polymer of glycosaminoglycan
family. It is an important constituent of the extracellular
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Table 2 – Result of multiple comparisons of VAS among groups and time points.
Group/time point Comparison Mean estimated
difference
Standard error t value gL p
Group 1 3 days–8 days 3.86 0.10 38.60 384 <0.001
3 days–15 days 5.20 0.13 41.05 384 <0.001
3 days–30 days 6.22 0.14 44.25 384 <0.001
3 days–60 days 7.02 0.15 47.27 384 <0.001
8 days–15 days 1.35 0.10 13.48 384 <0.001
8 days–30 days 2.37 0.13 18.67 384 <0.001
8 days–60 days 3.16 0.14 22.49 384 <0.001
15 days–30 days 1.02 0.10 10.21 384 <0.001
15 days–60 days 1.82 0.13 14.33 384 <0.001
30 days–60 days 0.80 0.10 7.97 384 <0.001
Group 2 3 days–8 days 2.27 0.10 22.67 384 <0.001
3 days–15 days 4.33 0.13 34.12 384 <0.001
3 days–30 days 6.37 0.14 45.26 384 <0.001
3 days–60 days 7.06 0.15 47.55 384 <0.001
8 days–15 days 2.06 0.10 20.63 384 <0.001
8 days–30 days 4.10 0.13 32.35 384 <0.001
8 days–60 days 4.80 0.14 34.09 384 <0.001
15 days–30 days 2.04 0.10 20.42 384 <0.001
15 days–60 days 2.73 0.13 21.57 384 <0.001
30 days–60 days 0.69 0.10 6.94 384 <0.001
3 days Group 1–Group 2 −0.10 0.16 −0.64 384 >0.999
8 days Group 1–Group 2 −1.69 0.16 −10.59 384 <0.001
15 days Group 1–Group 2 −0.98 0.16 −6.12 384 <0.001
30 days Group 1–Group 2 0.04 
60 days Group 1–Group 2 −0.06 
matrix and is present in high concentrations in cartilage and
synovial  ﬂuid.10
Some authors claim that sodium hyaluronate, which is
a  deﬁned fraction of hyaluronic acid, has analgesic and
anti-inﬂammatory properties, contributes to the normaliza-
tion  of ﬂuidity or viscoelasticity of the synovial ﬂuid and
to  the activation of tissue regeneration in the affected car-
tilage,  and restores the functional balance of the joint.
Therefore, they recommend its use for the treatment of
osteoarthritis.4,13,14
Some studies have reported that, in addition to relieving
pain  and improving function, the use of hyaluronic acid could
Table 3 – Result of multiple comparisons of Lysholm questionn
Group/time point Comparison Mean estimated
difference
Group 1 Pre–15 days 1.10 
Pre–30 days −43.47 
Pre–60 days −47.76 
15 days–30 days −44.57 
15 days–60 days −48.86 
30 days–60 days −4.29 
Group 2 Pre–15 days 12.02 
Pre–30 days −28.88 
Pre–60 days −41.84 
15 days–30 days −40.90 
15 days–60 days −53.86 
30 days–60 days −12.96 
Pre Group 1–Group 2 −1.73 
15 days Group 1–Group 2 9.18 
30 days Group 1–Group 2 12.86 
60 days Group 1–Group 2 4.18 0.16 0.26 384 >0.999
0.16 −0.38 384 >0.999
alter the course of osteoarthrosis and improve qualitatively
and  quantitatively the articular cartilage. These indications
are  based on studies of imaging such as X-ray and MRI,
in  which there was  an increase in cartilage volume and a
decrease  in joint space after the treatment versus placebo.
These  beneﬁts are also based on the best quality of the matrix
and  on a higher density of chondrocytes in biopsy studies after
the  implementation of treatment.4
In animal studies, Plaas et al.15 concluded that hyaluronic
acid suppresses synovial hyperplasia and the development
of  periarticular ﬁbrosis, and protect against cartilage erosion,
and  also acts to relieve pain in the short term (dilution of joint
aire among groups and time points.
Standard error t value gL p
0.28 3.92 288 0.003
0.33 −133.55 288 <0.001
0.34 −140.79 288 <0.001
0.28 −158.49 288 <0.001
0.33 −150.11 288 <0.001
0.28 −15.24 288 <0.001
0.28 42.74 288 <0.001
0.33 −88.72 288 <0.001
0.34 −123.34 288 <0.001
0.28 −145.43 288 <0.001
0.33 −165.47 288 <0.001
0.28 −46.08 288 <0.001
0.35 −5.01 288 <0.001
0.35 26.54 288 <0.001
0.35 37.16 288 <0.001
0.35 12.09 288 <0.001
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Fig. 2 – Graphical representation of the mean proﬁles and
respective  standard errors of Lysholm questionnaire,
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uid) and in the long term (blocking of pain receptors), and
mprove  the gait pattern of the osteoarthrosis knee.
Currently, the use of intra-articular hyaluronic acid is also
idely  discussed because of the different formulations, with
ifferent  molecular weights and the results of some meta-
nalyses.  These studies also differ in the parameter used and
urther  increase the discussion as to the effectiveness of its
se.16
Huang et al.,13 in a randomized, double-blind, multicen-
er study, evaluated in one sample of the Asian population
he  use of intra-articular hyaluronic acid versus placebo. These
uthors  found statistically signiﬁcant improvement in reduc-
ng  the pain and in the knee function, especially after the ﬁfth
eek  of treatment. These beneﬁts have remained effective for
p to 25 weeks. In the subjective evaluation, favorable results
ith  its use also were noted. Regarding the consumption of
cetaminophen and the volume of joint ﬂuid, there was  no
tatistically  signiﬁcant difference for any group.11
These results are consistent with the study by Navarro-
arabia et al.,17 in which there was  a statistically signiﬁcant
ifference in favor of hyaluronic acid in the categories of
ain  relief, improved function and overall improvement of the
atient  versus placebo.
Bannuru  et al.,14 in a meta-analysis comparative of the use
f  intra-articular hyaluronic acid versus placebo, concluded
hat  hyaluronic acid is effective as early as the fourth week
f  treatment, with peak effectiveness at eight weeks, and
emaining  beneﬁcial for up to 24 weeks. These authors eval-
ated  the effectiveness for pain relief, improved function and
ecreased  joint stiffness.
Lee  et al.18 believe that the analgesic effect of hyaluronic
cid in the ﬁrst ﬁve weeks is equal to that of placebo. In
heir  prospective and randomized study, the authors con-
luded  that the use of cetorolac associated with hyaluronic
cid  showed more  rapid analgesia versus monotherapy with
yaluronic  acid. In the ﬁfth week this analgesia achieved
qual intensity in both groups (hyaluronic acid with cetoro-
ac  × hyaluronic acid alone).
But  it is worth bearing in mind that the aforementioned
tudies evaluate the hyaluronic acid in the treatment of 4;4 9(1):37–43  41
osteoarthrosis; hence, it is interesting to quote them, because
they  discuss the efﬁcacy of hyaluronic acid as a means of
improving  function and pain.
Regarding the use of hyaluronic acid in the post-operative
of arthroscopy, Forster and Straw19 compared pain and func-
tion  in activities of daily living in patients with isolated
arthroscopy versus arthroscopy associated with hyaluronic
acid.  These authors concluded that there was improvement
of  function with the use of HA, but without difference in the
category  of pain.
Heybeli  et al.1 compared pain and function in patients
with 40–65 years old with mild to moderate osteoarthrosis
and who underwent arthroscopy with and without the use
of  hyaluronic acid (HA) post-operatively. There was no statis-
tically  signiﬁcant difference with respect to pain, but there
was  improvement in function in patients who  used HA. In our
study,  we  observed the same result with respect to function
improvement, mainly until the 30th day, both by the Lysholm
questionnaire and by the goniometer mensuration. However,
with  regard to pain, until the third day the results conﬁrm the
literature,  with no difference with the use of the medication
in  question; thereafter, patients treated with hyaluronic acid
had  less pain versus control group, and this analgesia achieved
equal  intensity in the 30th day-evaluation and from then on.
Hempﬂing10 also contrasted isolated arthroscopy versus
arthroscopy associated with HA in the items of night pain,
pain  when walking, and ability to walk 100 meters with-
out  pain. A clear symptomatic improvement occurred in
both  groups, compared with preoperative values; but in the
group  using HA this improvement lasted longer. In our
study,  there was  also signiﬁcant improvement in pain and
function  versus preoperative assessments, but this differ-
ence  was  observed in the initial evaluations. After the 60th
day,  an important difference between the ratings of Groups
1  and 2 was not observed, which can be justiﬁed by the
lack  of assessment of patients over a longer period, when
maybe  we could observe results equivalent to the litera-
ture.
In  2007, Ulucay et al.20 compared the use of three types
of  HA in women 40–60 years old with mild osteoarthrosis
and degenerative meniscal lesion, after arthroscopy. These
authors  concluded that HA is effective therapy for these
patients.
Also  in 2008, Atay et al.21 compared the effect of HA of
high  and low molecular weight versus placebo in terms of
pain,  stiffness and functional ability at six and 12 months after
arthroscopic  debridement in patients with mild to moderate
osteoarthrosis. After six months, there was  no statistically
signiﬁcant difference, but this occurred after 12 months. The
authors  concluded that the use of HA results beneﬁcial and
improves  the effectiveness of treatment, regardless of the
substance’s  high or low molecular weight. In our study, pain
improvement was  observed until the 15th day, with better
range  of motion and functional capacity until the 30th day.
There  was  no statistical difference for the items evaluated
from  the 60th day.
2Waddell  and Bert, in a systematic review conducted in
2010,  concluded that more  studies are necessary to support
the  use of HA in the post-operatory of knee arthroscopy
patients. However, it seems that the use of HA helps to
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decrease pain and improve the function of a signiﬁcant num-
ber  of patients post-operatively. In our study, the improvement
of  pain, function, and range of motion in patients who were
treated  with HA inﬁltration was  observed. The improvement
of  pain is observed in the initial stage, especially until the
15th  day; on the other hand, the function and range of motion
improved  after this period. We  believe in a direct relation with
this  effect: with less pain, the patient can achieve a faster reha-
bilitation,  with more  quality, besides a faster return to his/her
daily  functions.
When interpreting more  deeply the Lysholm question-
naire, our results demonstrated, in the initial evaluation, that
although  both groups were classiﬁed as poor, the superi-
ority  of the patients in Group 1 was  justiﬁed by the best
assessments in relation to pain and swelling. This ﬁnding
corroborates the results of VAS and can be explained by the
analgesic  and anti-inﬂammatory effect of hyaluronic acid.
4,13,14
In the 30th day evaluation, we found the greatest difference
between Groups 1 and 2: 90 and 77 points, respectively. The
main  differences are in the item “swelling”, again because the
anti-inﬂammatory effect of HA. As of “claudication”, “instabil-
ity”  and “squatting”, we  believe that, by this time, with a more
effective  therapy and because of a lower intensity of pain,
it  is possible that the patient be submitted to more  intense
demands and achieve an earlier gain of muscle mass and
proprioception. This would facilitate the activities above eval-
uated. From the 30th, the pain was  similar in both groups,
and  in the assessment of the 60th day both groups were clas-
siﬁed  as good, with statistical superiority in Group 1 versus
Group  2 (94 × 90, respectively). This superiority was  due to the
improved  ability to climb stairs by Group HA patients, likely
due  to the better muscle reserves acquired in the initial 60
days.
Conclusion
Given the subjective parameters evaluated, we believe that
the  use of intra-articular inﬁltrations of sodium hyaluronate
20  mg  in procedures of arthroscopic surgery of the knee is
fully  justiﬁed, as this practice leads to a decrease in pain in
the  initial phase, enables faster patient recovery and gener-
ates  a faster return and better quality to the activities of daily
living.
Our  study has some limitations: the short period of eval-
uation  of patients (we were  unable to verify the effects of
hyaluronic  acid in the medium and long term), and also the
fact  of the subjectivity of the evaluation of patients’ function.
This  implies that perhaps an isokinetic evaluation with cybex
could  better demonstrate a muscle differences between the
two  groups of individuals. We  believe that this is the main
cause  of improvement of the function on the 60th day. Unfor-
tunately,  we  could not proceed with this option for lack of
money.Conﬂicts  of  interest
The authors declare no conﬂicts of interest.
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